208
Participants
Start Date
October 10, 2017
Primary Completion Date
September 10, 2018
Study Completion Date
October 22, 2018
SNA-120
Pegcantratinib ointment
Vehicle
Placebo ointment to mimic Pegcantratinib ointment
Site 037, Rochester
Site 031, Pittsburgh
Site 032, Rockville
Sienna 014, Norfolk
Sienna 006, Winston-Salem
Sienna 016, High Point
Site 029, Macon
Site 026, Doral
Sienna 017, North Miami Beach
Site 027, West Palm Beach
Sienna 019, Largo
Sienna 024, Ocala
Site 035, Murfreesboro
Sienna 023, Louisville
Sienna 011, Plainfield
Sienna 010, New Albany
Site 039, Clarkston
Sienna 002, Fridley
Sienna 001, St Louis
Site 038, Metairie
Sienna 022, Fort Smith
Site 041, Norman
Sienna 021, Dallas
Sienna 018, Houston
Site 034, Pflugerville
Sienna 012, Austin
Sienna 015, Denver
Sienna 007, Murray
Site 025, Scottsdale
Sienna 013, Albuquerque
Sienna 020, Santa Monica
Sienna 008, San Diego
Site 028, Fountain Valley
Sienna 009, Fremont
Sienna 003, Portland
Sienna 005, Farmington
Site 030, Shelton
Sienna 004, East Windsor
Lead Sponsor
Sienna Biopharmaceuticals
INDUSTRY